Predictive molecular pathology in the time of COVID-19.
Umberto MalapelleCaterina De LucaAntonino IaccarinoFrancesco PepePasquale PisapiaMaria RussoRoberta SgarigliaMariantonia NacchioElena VigliarClaudio BellevicineFernando C SchmittGiancarlo TronconePublished in: Journal of clinical pathology (2020)
In the times of coronavirus, laboratory fully automated platforms simplify predictive molecular testing. Laboratory staff may be more safely and cost-effectively managed.